Bulk RNA sequencing of sorted inguinal LN CD11c+ cells from healthy mice and mice subcutaneously implanted with KPC tumor both untreated and treated with CD40 agonist. Overall design: n=4 per group. Groups: Healthy, Tumor-Draining LN, Tumor-Draining LN CD40 agonist